We are currently seeking Senior Research Fellows/ Academic Level C – join us as we strengthen our immunotherapy research program. Apply now.
The enormous specificity and diversity of the immune system is integral for the control of infection and cancer, along with the development of allergies and autoimmune disease. Consequently the capacity to generate targeted immune responses or manipulate the quality of immune responses offers significant opportunities. This is evident not only in the impact of vaccines, which can prevent life-threatening infection but in the recent development of therapeutic approaches that target so-called “checkpoint inhibitors”, which have become prominent in the treatment of cancer.
The University of Melbourne has significant research strengths in basic immunology and is seeking to enhance its capacity for translational research. We are building programs of research to develop defined immunotherapeutics on immunoregulation strategies that have direct clinical application, particularly in cancer, infection, allergy and autoimmune disease.
The University of Melbourne is seeking new researchers at academic level C who can join in and benefit from our developing critical mass of research talent and facilities for immunotherapy research. We are seeking researchers with demonstrated expertise to build an internationally competitive research program in:
- translational immunology
- vaccine research/development
- therapeutic antibody technology
- cancer immunotherapy.
Applications are open until 24th July 2018 and will require a:
- cover letter
- response to selection criteria.
For enquiries please email: firstname.lastname@example.org
|Key partners, schools and centres at the University of Melbourne involved in immunotherapy research:|